1Folkman J. Tumor angiogenesis therapeatic implications. N Engl J Med.1971;285(21):1182- 1186.
2Q'Reilly MS, Boehm T,Shing Y,et al. Endostatin an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88(2) : 277 - 285.
3Welsh LC, Welsh M, Ito N,et al. Angiostatin induces endothelial cell apoptosls and activation of focal adhesion kinase independently of the intergin- binding motif RGD. Proc Nail Acda Sci USA, 1998; 95 (10) : 5579 - 5583.
5Patterson Be, Sang QA. Angiostatin - converting enzyme activities of human matrilysin(MMP- 7)and gelatinase B/type Ⅳ collageaase (MMP - 9). J Biol Chem, 1997; 272 (46):28823 - 28825.
6Moser TL,Stack MS,Asplin I,et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA, 1999;96(6) :2811 - 2816.
7Cornelius LA, Nehring LC, Harding E, et al. Matrix metalloprotelnases generate angiostatin: effects on neovascularization.J Immunol, 1998; 161(12) :6845 - 6852.
8Dhanabal M, Volk R,Ramchancdran R,et al. Cloning, expression,and in vitro activity of human endcstatin. Biochem Biophys Res Comman, 1999;258(2):345 - 352.
9Dhanabal M,Ramchancdran R,Volk R,et al. Endostatin:yest production, mutants, and antitumor effece in renal cell carcinoma. Cancer Res, 1999; 59 (1) : 189 - 197.
10Feldman AL, Alexander HR, Yang JC, et al. Prospective analysis of circtdating endostatin levels in patients with renal cell carcinoma. Cancer,2002;95(8) : 1637- 1643.
